Compare ANIX & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | PROV |
|---|---|---|
| Founded | 1982 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.6M | 103.7M |
| IPO Year | 2013 | 2009 |
| Metric | ANIX | PROV |
|---|---|---|
| Price | $2.81 | $17.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $16.25 |
| AVG Volume (30 Days) | ★ 111.0K | 6.2K |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 12.82 | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | ★ $210,000.00 | N/A |
| Revenue This Year | N/A | $4.14 |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | ★ N/A | $25.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.44 | $14.85 |
| 52 Week High | $5.46 | $17.42 |
| Indicator | ANIX | PROV |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 56.17 |
| Support Level | $2.81 | $16.93 |
| Resistance Level | $3.12 | $17.38 |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 15.28 | 31.48 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.